688163 赛伦生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.0514.6914.0613.5138.610
总资产报酬率 ROA (%)0.0494.5483.9403.3798.181
投入资产回报率 ROIC (%)0.0504.6514.0083.4468.387

边际利润分析
销售毛利率 (%)72.65578.12178.05775.70983.770
营业利润率 (%)1.74632.87726.67024.18442.855
息税前利润/营业总收入 (%)1.66932.04125.08422.67240.964
净利润/营业总收入 (%)2.09326.39422.72320.39236.849

收益指标分析
经营活动净收益/利润总额(%)-263.89786.739101.80188.00678.660
价值变动净收益/利润总额(%)744.40716.48610.22322.75621.667
营业外收支净额/利润总额(%)-12.505-0.469-2.806-1.252-0.843

偿债能力分析
流动比率 (X)26.39524.71546.70037.97937.104
速动比率 (X)25.03223.54944.49536.18835.075
资产负债率 (%)3.5643.8502.1903.7783.845
带息债务/全部投入资本 (%)0.3810.3510.2270.3330.294
股东权益/带息债务 (%)25,947.76728,159.14143,849.60829,465.78033,387.045
股东权益/负债合计 (%)2,705.4542,497.3914,465.3532,547.0122,500.496
利息保障倍数 (X)14.212-46.896-29.206-18.689-26.735

营运能力分析
应收账款周转天数 (天)141.58566.73254.77528.69717.841
存货周转天数 (天)541.036361.884370.449386.922660.221